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Abstract
Background: Evidence suggests that both the migration and activation of neutrophils into the
airway is of importance in pathological conditions such as pulmonary emphysema. In the present
study, we describe in vivo models of lung neutrophil infiltration and activation in mice and hamsters.
Results: BALB/c and C57BL/6 mice were intranasally treated with lipopolysaccharide (0.3 mg/kg).
Twenty-four hours after, animals were treated intranasally with N-Formyl-Met-Leu-Phe (0 to 5 mg/
kg). Golden Syrian hamsters were treated intratracheally with 0.5 mg/kg of lipopolysaccharide.
Twenty-four hours after, animals were treated intratracheally with 0.25 mg/kg of N-Formyl-Met-
Leu-Phe. Both mice and hamster were sacrificed two hours after the N-Formyl-Met-Leu-Phe
application. In both BALB/c and C57BL/6 mice, a neutrophil infiltration was observed after the
sequential application of lipopolysaccharide and N-Formyl-Met-Leu-Phe. However, 5 times less
neutrophil was found in C57BL/6 mice when compared to BALB/c mice. This was reflected in the
neutrophil activation parameters measured (myeloperoxidase and elastase activities). Despite the
presence of neutrophil and their activation status, no lung haemorrhage could be detected in both
strains of mice. When compared with mice, the lung inflammation induced by the sequential
application of lipopolysaccharide and N-Formyl-Met-Leu-Phe was much greater in the hamster. In
parallel with this lung inflammation, a significant lung haemorrhage was also observed.
Conclusions: Both mouse and hamster can be used for pharmacological studies of new drugs or
other therapeutics agents that aimed to interfere with neutrophil activation. However, only the
hamster model seems to be suitable for studying the haemorrhagic lung injury process.
Background
Several lines of evidences suggest that elastase may play an
important role in certain pathological conditions such as
pulmonary emphysema [1]. Neutrophils could be impli-
cated in the development of emphysema because they are
the major source of enzymes with elastolytic activity in the
lung [2]. Nevertheless, alveolar neutrophilia is not a pre-
requisite for the development of pulmonary emphysema
since in airway diseases like asthma, acute respiratory dis-
tress syndrome and cystic fibrosis an increased number in
bronchoalveolar lavage neutrophils is observed without
any air space enlargement. These observations suggest that
the activation of neutrophils migrating into the airway
(e.g. release of elastase) is of importance in lung destruc-
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an in vivo model in which the neutrophil migration and
activation into the lung could be studied.
Lipopolysaccharide (LPS) is a macromolecular cell surface
antigen of bacteria which, when applied in vivo triggers a
network of inflammatory responses. One of the primary
events is the activation of mononuclear phagocytes
through a receptor-mediated process, leading to the re-
lease of a number of cytokines, including tumor necrosis
factor-α (TNF-α) [4]. In turn, the increased adherence of
neutrophils to endothelial cell induced by TNF-α leads to
a massive infiltration in the pulmonary space [5]. Al-
though LPS-induced lung inflammation has been used
mainly as an acute respiratory distress syndrome model,
the main characteristics of this model, macrophage activa-
tion, TNF-α production and neutrophil infiltration and
activation, are also features of chronic obstructive pulmo-
nary diseases. Intraperitonial [6] and intravenous [7] in-
jections of bacterial LPS are the most common
administration used to develop acute lung injury in ani-
mal models. Using these methods of administration pul-
monary lung inflammation can be measured by albumin
extravasation or neutrophil myeloperoxidase activity in
the lung parenchyma [6,7]. The drawback of these models
is that neutrophils do not infiltrate into the lung paren-
chyma. Although these models are very useful to unravel
the mechanisms of neutrophil trafficking and/or TNF-α
production, there are not suitable to measure lung neu-
trophil activation. Intranasal administration of LPS in
mice have been reported to induce bronchoalveolar lav-
age neutrophil influx and lung damage as measure by
bronchoalveolar lavage haemorrhage [8]. However, only
a small increase in bronchoalveolar lavage haemoglobin
content was reported (2 times) which suggest that this
model might not be suitable for compound screening.
N-formyl-methionyl-leucyl-phenylalaline (fMLP) is a
powerful activator of both neutrophils and macrophages.
The main response elicited by fMLP is the generation of
reactive oxygen species and the release of lysosomal en-
zymes such as myeloperoxidase and elastase [9]. In this re-
port, we describe a model of neutrophil activation in vivo
using either BALB/c or C57BL/6 mice and Golden Syrian
hamsters and show that although BALB/C mice and Gold-
en Syrian hamsters can be used to study neutrophil activa-
tion, only the hamster seems to be suitable for studying
the haemorrhagic lung injury process.
Results
LPS-induced neutrophilic inflammation in BALB/c mice
A dose dependent increase in bronchoalveolar lavage neu-
trophil numbers and total cell count, associated with a
dose-dependent decrease in macrophage numbers, was
observed as early as 3 h after the LPS challenge (Fig. 1). An
increase in lymphocyte numbers was observed only with
0.3 mg/kg of LPS. There were no eosinophils in the PBS-
challenged mice and LPS did not induced any increase in
this cell type (data not shown).
When compared with the 3 h time point, a similar pattern
of response was observed at 24 h post LPS challenge (dose
dependent increase in neutrophil, total cell count and
lymphocyte and no effect on eosinophils). However, the
magnitude of the inflammation was about twice as much.
In contrast, the macrophage number did not vary (Fig. 1).
LPS-induced a dose dependent increase in the levels of
TNF-α at the 3 h time point (Table 1) and no TNF-α could
be detected at the 24 h time point (data not shown).
At 3 h post LPS challenge, the myeloperoxidase activity
was significantly increased only with the highest dose (0.3
mg/kg). In contrast, 24 h after LPS challenge, all the doses
used (0.05 to 0.3 mg/kg) induced a significant increase in
bronchoalveolar lavage myeloperoxidase activity (Table
1). No elastase activity could be detected in the broncho-
alveolar lavage at the 3 hours time point (data not
shown). However, 24 h after LPS a dose-dependent in-
crease in the bronchoalveolar lavage elastase activity was
observed (Table 1). At both time points, no bronchoalve-
olar lavage haemorrhage could be measured (data not
shown).
In a separate experiment, BALB/c mice were challenged
with 0.3, 0.5 or 1 mg/kg of LPS and sacrificed 24 hours af-
ter. As shown in table 2, when compared with 0.3 mg/kg
of LPS, neither the neutrophil infiltration nor their activa-
tion (MPO and elasatase levels) were further increase. For
Figure 1
Bronchoalveolar cellular infiltration 3 and 24 hours after the
LPS challenge in BALB/c mice. Animals were intranasally chal-
lenged with increasing concentrations of LPS (0.05 to 0.3 mg/
kg) or PBS alone (50 µl). Three or 24 hours after the chal-
lenge, animals were sacrificed and bronchoalveolar lavage
performed. Data are expressed as mean ± SEM from two dif-
ferent experiments each included 6 mice per group. Signifi-
cance (P < 0.050, versus PBS challenged mice, is indicated by
*. Neutro: neutrophils; Macro: macrophages; Lympho: lym-
phocytes; TCC: total cell counts.Page 2 of 8
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could be measured (data not shown).
LPS/fMLP-induced lung neutrophil influx and activation in 
BALB/c and C57BL/6 mice
In agreement with the results above, when compared with
PBS-challenged BALB/c mice, LPS induce an increase of
neutrophils and lymphocytes in the bronchoalveolar lav-
age at the 24 hours time point (Fig. 2). In C57BL/6 mice,
neutrophils were the only cell types increase after LPS (Fig.
2). Moreover, about 6 times less neutrophils were found
in the bronchoalveolar lavage from C57BL/6 mice when
compared to BALB/c mice.
When added for 2 h, 24 h after the LPS, fMLP-induced a
dose-dependent increase in bronchoalveolar lavage eosi-
nophils, which was significant for the highest dose used
(5 mg/kg). The influx of the others cell types, including
macrophages (data not shown), were not affected by the
addition of fMLP (Fig. 2). In both strains of mice, fMLP,
on his own at 5 mg/kg, had no effect on the bronchoalve-
olar lavage cellular content (Fig. 2).
In BALB/c mice, LPS-induced an increase in myeloperoxi-
dase activity, and this activity was further increased, in a
dose dependent manner, by fMLP (Fig. 3). However a sig-
nificant increase, when compared with LPS-treated mice,
was observed only at the highest dose of fMLP, 5 mg/kg
(Fig. 3). fMLP on his own, at 5 mg/kg, induce a significant
increase in the myeloperoxidase activity, when compared
with PBS/Vehicle treated mice. This probably reflects the
activation of the small population of neutrophils present
after the PBS application (Table 1). In C57BL/6 mice, LPS
application did not induce an increase in the myeloperox-
idase activity when compared with PBS treated mice. A
dose response to fMLP, following LPS, was observed and
a significant increase over the LPS-treated group was ob-
tained from 2 mg/kg of fMLP (Fig. 3). For both strains of
mice, in the PBS/Vehicle treated mice, very low levels of
myeloperoxidase activity could be detected in the bron-
choalveolar lavage (Fig. 3).
In BALB/c mice, LPS induce an increase in the bronchoal-
veolar lavage elastase activity, and this activity was further
increased, in a dose dependent manner, by fMLP. A signif-
Table 1: Levels of bronchoalveolar lavage myeloperoxidase (MPO) activity, elastase activity and TNF-α following LPS challenge in 
BALB/c mice.
TNF-α 3 h (ng/ml) MPO 3 h (mU/ml) MPO 24 h (mU/ml) Elastase 24 h (ng/ml)
PBS (50 µl) 0 ± 0 5.1 ± 4.8 56.7 ± 7.2 0 ± 0
LPS (0.05 mg/kg) 4.5 ± 0.6* 4.5 ± 2.4 733.3 ± 103.4* 18.3 ± 1.23 *
LPS (0.1 mg/kg) 15.3 ± 1.2* 14.1 ± 8.3 961.8 ± 320.4* 62.5 ± 3.5*
LPS (0.3 mg/kg) 24.5 ± 1.45* 35.4 ± 5.2* 1209.8 ± 170.4 * 252.1 ± 18.5*
Animals were intranasally challenged with increasing concentrations of LPS (0.05 to 0.3 mg/kg) or PBS alone (50 µl). Three or 24 hours after the 
challenge, animals were sacrificed and bronchoalveolar lavage performed. Data are expressed as mean ± SEM from two different experiments each 
included 6 mice per group. Significance, (P < 0.05) indicated by (*) is versus PBS-challenged mice
Table 2: Bronchoalveolar lavage inflammation in BALB/c mice 24 hours after the challenge with 0.3, 0.5 or 1 mg/kg of LPS.
PBS (50 µl) LPS (0.3 mg/kg) LPS (0.5 mg/kg) LPS (1 mg/kg)
Neutrophils (× 105 cells/ml) 0.66 ± 0.21 9.9 ± 1.1* 10.1 ± 0.8* 11.6 ± 2.4*
Macrophages (× 105 cells/ml) 1.65 ± 0.23 1.24 ± 0.4 1.43 ± 0.07 1.69 ± 0.21
Lymphocytes (× 105 cells/ml) 0.02 ± 0.01 0.10 ± 0.02* 0.06 ± 0.01* 0.10 ± 0.07*
Total cell counts (× 105 cells/ml) 2.34 ± 0.29 10.29 ± 1.09* 11.6 ± 0.8* 13.4 ± 2.6*
MPO (mU/ml) 41.2 ± 0.007 1045.5 ± 178.6* 1451.7 ± 123.4* 1235.8 ± 368.7*
Elastase (ng/ml) 0 ± 0 264.4 ± 21.9* 215.8 ± 8.5* 287.5 ± 21.4*
Animals were intranasally challenged with 0.3, 0.5 or 1 mg/kg of LPS or PBS alone (50 µl). Twenty four hours after the challenge, animals were sac-
rificed and bronchoalveolar lavage performed. Data are expressed as mean ± SEM 6 mice per group. Significance, (P < 0.05) indicated by (*) is versus 
PBS-challenged mice.Page 3 of 8
(page number not for citation purposes)
BMC Pharmacology 2002, 2 http://www.biomedcentral.com/1471-2210/2/1icant increase, when compared with LPS-treated mice was
observed only at the highest dose of fMLP. fMLP alone, at
5 mg/kg, had no effect on the bronchoalveolar lavage
elastase content (Fig. 3). In C57BL/6 mice, LPS applica-
tion did not induce an increase in the elastase activity
when compared with PBS treated mice. fMLP induce a
dose dependent increase in the bronchoalveolar lavage
elastase activity and a significant increase, when com-
pared with LPS-treated mice, was observed only at the
highest dose of fMLP (Fig. 3). In the PBS/Vehicle treated
mice, no elastase activity could be detected in the bron-
choalveolar lavage of both strains of mice (Fig. 3). Despite
the presence of myeloperoxidase and elastase activity in
the bronchoalveolar lavage, in both strains of mice, no
bronchoalveolar lavage haemorrhage was evident (data
not shown).
LPS/fMLP-induced lung neutrophil influx and activation in 
Golden Syrian Hamster
As seen in the mice, LPS application results in a neutrophil
infiltration into the bronchoalveolar lavage of the ham-
ster (Fig. 4). When added 24 h after the LPS, fMLP (0.25
mg/kg) induce a significant increase in bronchoalveolar
lavage eosinophils and lymphocytes. The influx of the
others cell types, including macrophages (data not
shown), were not affected (Fig. 4). Concomitant with the
neutrophil influx induced by LPS, myeloperoxidase and
elastase activities were also present in the bronchoalveolar
lavage. This activities were further increase (about 4 and
10 times for myeloperoxidase and elastase respectively)
following fMLP (Fig. 5). In contrast to the results observed
in mice, bronchoalveolar lavage hemorrhage was evident
in the hamster after LPS treatment and the hemorrhage
was further increase by the addition of fMLP (Fig. 5).
Discussion
The present study shows that the in vivo intranasal admin-
istration of LPS in BALB/c mice induced a dose- and time-
dependent invasion of the airway lumen with neu-
trophils. The chronology of this inflammatory response in
the lung was evaluated by the analysis of inflammatory
cell count in the bronchoalveolar lavage, reflecting their
extravasation from the vascular lumen to the airway air-
space, and by the measurement of myeloperoxidase and
Figure 2
Bronchoalveolar differential cell counts following sequential application of LPS and fMLP in BALB/c and C57BL/6 mice. Animals
were intranasally challenged with LPS (0.3 mg/kg intranasally) or PBS (50 µl). Twenty four hours after the challenge, mice were
intranasally challenged with increasing concentrations of fMLP (0.5–5 mg/kg) or 50 µl of vehicle (1% DMSO in PBS). Two hours
after the second challenge, animals were sacrificed and bronchoalveolar lavage performed. Data are expressed as mean ± SEM
from 5–9 mice per groups. Significance (P < 0.05), indicated by (*) or (#) is versus PBS-challenged/Vehicle-treated mice and
LPS-challenged/Vehicle-treated mice, respectively.Page 4 of 8
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the activation of neutrophils. It has been shown, in mice,
that an increase in neutrophil proteases activity do not
neceserally translate into lung damages [10]. Therefore,
we also meassured lung haemorrage as a possible surro-
gate marker of the lung destruction process. In BALB/c
mice, examination of varying the concentrations of LPS
clearly indicates a dose-dependent neutrophilic lung infil-
tration. A dose of 0.3 mg/kg of LPS instilled into the lung
induces the optimal acute pulmonary inflammation since
no further increase in neutrophil numbers and activation
could be observed at doses of 0.5 and 1 mg/kg. The results
obtained from the time course experiment clearly showed
that an acute neutrophilia could be achieved as soon as 3
hours after the LPS challenge. However, in order to meas-
ure a reasonable activation of the infiltrating neutrophils
the 24 hours time point post challenge is needed. After 5
days, the neutrophils in the bronchoalveolar lavage return
to baseline levels and the mice recovered on their own
from the induced trauma (data not shown). These results
shown that intranasal administration of low amount of
LPS in BALB/c mice results in an acute and well controlled
pulmonary neutrophilia.
Apart from the massive influx of neutrophils, which rep-
resent about 90–95% of the total cells in the bronchoalve-
olar lavage, a small but significant increase in
lymphocytes was also observed.. Macrophages did not in-
crease in a significant manner after LPS. In contrast, a sig-
nificant decrease was observed following LPS challenge
only at the earlier time point (3 hours). This observation,
in agreement with a previous report [8], probably reflects
macrophages adherence to the alveolar surface. Infiltrat-
ing neutrophils were also activated after the LPS challenge
as evidenced by the increase levels of MPO and elastase ac-
tivities. However, despite the massive neutrophil influx
into the airway space of BALB/c mice and their activation
status, no bronchoalveolar lavage haemorrhage was evi-
dent. Therefore, another model of lung neutrophil infil-
tration and activation was studied.
fMLP has been shown to exaggerate the increase in airway
resistance induced by LPS in anaesthetized guinea pigs
[11]. Similarly, ex vivo experiments have shown that fMLP
increased vasoconstriction and edema formation in lungs
from endotoxin-primed rats [12]. Based on these observa-
tions, we speculated that the sequential intranasal admin-
istration of LPS and fMLP, 24 hours apart, might increase
the neutrophil activation and therefore increase the haem-
orrhagic lung injury. In this model, we have compared
BALB/c and C57BL/6 mice, the latter being described as a
strain deficient in α1-proteinase inhibitor [10], with the
idea that C57BL/6 will present more serious lung haemor-
rhage. Interestingly enough, while a good and reproduci-
ble LPS-induced inflammation was observed in the BALB/
c, only a small neutrophilic influx was induced in C57BL/
6. The reason for this is unknown, however it is well
known that inbred mouse strains varied in sensitivity to
different stimuli [13,14]. Because C57BL/6 mice were
poor responder to LPS, we went on to modify a procedure
describing a model of neutrophil-induced lung damages
in Golden Syrian hamsters, another species deficient in
α1-proteinase inhibitor [15]. In both strains of mice and
in hamsters, the application of fMLP 24 h after LPS in-
duced a small but significant increased in eosinophil
Figure 3
Bronchoalveolar lavage activities for myeloperoxidase (MPO)
and elastase activities in BALB/c and C57BL/6 mice following
the sequential application of LPS and fMLP. Animals were
intranasally challenged with LPS (0.3 mg/kg) or PBS alone (50
µl). Twenty four hours after the provocation, increasing con-
centrations of fMLP (0.5 to 5 mg/kg) or 50 µl of vehicle (PBS,
1% DMSO) were applied intranasally. Two hours after the
second challenge, animals were sacrificed and bronchoalveo-
lar lavage performed. Data are expressed as mean ± SEM
from two different experiments each included 5–9 mice per
group. Significance (P < 0.05), indicated by (*) or (#) is versus
PBS-challenged/Vehicle-treated mice and LPS-challenged/
Vehicle-treated mice, respectively.Page 5 of 8
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ance with the properties of fMLP which has been de-
scribed as a chemoattractant for eosinophils [16]. It is
somewhat surprising that no further increase in neu-
trophil numbers was observed after the addition of fMLP
since this peptides has been described as a powerful neu-
trophil chemoattractant when given intratracheally in
mice [10]. However, in this report the earlier time point
studied was 24 hours post challenge [10], whereas in the
present study, animals were sacrificed 2 hours after the
fMLP challenge. Moreover, in our case fMLP was applied
into the airway of animals which have been previously
treated with LPS and the chemoattractant activity of fMLP
could have been masked by the ongoing neutrophilic in-
flammation. In both strains of mice, fMLP-induce a dose-
dependent increase in the resident neutrophil activation,
as measured by bronchoalveolar lavage myeloperoxidase
and elastase activities. However, none of the strains seems
to develop lung haemorrhage. Although, BALB/c mice
seems to be better than C57BL/6 for studying the neu-
trophil infiltration and activation processes following LPS
application in vivo, none of these strains seems to be suit-
able for studying the haemorrhagic lung injury process.
In hamsters, when compared with mice, the extent of the
lung inflammatory cells infiltration induced by the se-
quential application of LPS and fMLP was much greater
and the influx of neutrophils was followed by the devel-
opment of haemorrhagic lung injury. The difference in
susceptibility of BALB/C mice and hamsters to the devel-
opment of haemorrhagic lung injury after fMLP instilla-
tion could be explained by the fact that hamsters are
deficient in α1-proteinase inhibitor [15]. This is support-
ed by the observation that, although the bronchoalveolar
lavage neutrophilia is much more pronounced in the
hamsters following LPS instillation, these cells seem to be
less responsive to fMLP. Indeed, similar levels of broncho-
alveolar lavage myeloperoxidase activity were measured
in BALB/c and hamsters following the sequential applica-
tion of LPS and fMLP. Moreover, the bronchoalveolar lav-
age elastase activity was even less in the hamsters when
compared with BALB/c mice.
Conclusions
We have developed acute models of lung neutrophilic in-
flux and activation in both mice and hamsters. Both spe-
cies can be used for pharmacological studies of new drugs
or other therapeutics agents that aimed to interfere with
neutrophil infiltration and activation. However, only the
hamster model seems to be suitable for studying the
haemorrhagic lung injury process.
Figure 4
Bronchoalveolar differential cell counts following sequential
application of LPS and fMLP in hamsters. Animals were intrat-
racheally challenged with LPS (0.5 mg/kg intratracheally) or
PBS (100 µl). Twenty four hours after, hamsters were intrat-
racheally challenged with 0.25 mg/kg of fMLP or 100 µl of
vehicle (1% DMSO in PBS). Two hours after the second chal-
lenge, animals were sacrificed and bronchoalveolar lavage
performed. Data are expressed as mean ± SEM from 5–6
hamsters per group. Significance (P < 0.05), indicated by (*)
or (#) is versus PBS-challenged/Vehicle-treated hamsters and
LPS-challenged/Vehicle-treated hamsters, respectively.Page 6 of 8
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Animals
The animals, purchased from Harlan (Oxon, U.K.), were
housed in plastic cages in air-conditioned room at 22°C in
a 12 hours light-dark cycle. Food and water were available
ad libitum, The studies reported here conformed to the
U.K. Animals (scientific procedures) Act 1986.
LPS-induced lung inflammation
Female BALB/c mice (20–25 g, 5–6 weeks) were treated
intranasally, under Halothane/oxygen/nitrous oxide an-
aesthesia, with increasing concentration of LPS (Salmonel-
la Typhosa, Sigma, Poole, U.K.) in 50 µl of sterile
phosphate buffered saline (PBS) or with sterile PBS alone.
Three or 24 hours after the provocation, terminal anaes-
thesia was induced with pentobarbitone sodium (60 mg/
kg, i.p.).
LPS/fMLP induced lung neutrophil activation
Female C57BL/6 and BALB/c mice (20–25 g, 5–6 weeks)
were treated intranasally, under Halothane/oxygen/ni-
trous oxide anaesthesia, with 0.3 mg/kg of LPS (Salmonella
Typhosa, Sigma, Poole, U.K.) in 50 µl of sterile PBS or with
sterile PBS alone. Twenty-four hours after, animals were
treated intranasally with increasing concentrations of N-
Formyl-Met-Leu-Phe (fMLP, 0.5 to 5 mg/kg) or 50 µl of
the vehicle (1% DMSO in PBS).
For the Golden Syrian hamsters, a procedure modified
from [15] was used. Male hamsters (90–100 g, 8–9 weeks)
were treated intratracheally, under Halothane/oxygen/ni-
trous oxide anaesthesia, with 0.5 mg/kg of LPS (Salmonella
Typhosa, Sigma, Poole, U.K.) in 100 µl of sterile PBS or
with sterile PBS alone. Twenty-four hours after, animals
were treated intratracheally with 0.25 mg/kg of fMLP or
100 µl of the vehicle (1% DMSO in PBS).
Both mice and hamster were sacrificed two hours after the
fMLP application.
Assessment of lung inflammatory cells
Once the animal anaesthetised, the abdominal cavity was
opened and the animal exsanguinated by withdrawal of
blood from a major vessel. The trachea was cannulated
and bronchoalveolar lavage was performed by injecting 4
times the estimated tidal volume, 0.3 ml for mice and 1
ml for hamsters, of PBS into the lung via the trachea. The
fluid was then immediately withdrawn and the cell sus-
pension stored on ice. The recovery from lavage was com-
parable between species: 83.3 ± 6.8, 79.5 ± 8.5 and 80.6 ±
5.4 % for BALB/c, C57BL6 and Golden Syrian hamsters,
respectively. Total cell counts were measured and cytospin
preparation prepared (Shandon Scientific Ltd, Cheshire,
UK). Cells were stained with Dif-Quik (Baxter Dade AG,
Dudingen, Switzerland) and a differential count of 200
Figure 5
Bronchoalveolar lavage levels for myeloperoxidase (MPO)
activity, elastase activity and haemoglobin levels in hamsters
following the sequential application of LPS and fMLP. Animals
were intratracheally challenged with LPS (0.5 mg/kg) or 100
µl of PBS. Twenty four hours after, fMLP (0.25 mg/kg) or 100
µl of vehicle (Veh, 1%DMSO in PBS) was applied intratrache-
ally. Animals were sacrificed two hours after the second chal-
lenge and bronchoalveolar lavage performed. Data are
expressed as mean ± SEM from 2 different experiments each
included 5–10 animals per group. Significance (P < 0.05), indi-
cated by (*) or (#) is versus PBS-challenged/Vehicle-treated
hamsters and LPS/Vehicle treated hamsters, respectively.Page 7 of 8
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standard morphological criteria. The remaining lavage
fluids were centrifuged at 400 × g for 10 minutes, the su-
pernatant was aliquoted and either used immediately or
stored at -80°C.
Bronchoalveolar lavage soluble mediators measurement
bronchoalveolar lavage myeloperoxidase activity was
measured on fresh bronchoalveolar lavage supernatant
using a 96 well plate format colorometric assay modified
from [6]. Fifty µl of the samples, in duplicate, were mixed
with 100 µl of the substrate buffer for 5 minutes at room
temperature (sodium phosphate 50 mM, pH 6.0 contain-
ing, 0.5 % hexadecyltrimethylammonium bromide, 0.167
nM O-dianiside dihydrochloride and 0.4 mM H2O2). The
reaction was stopped with 100 µl of 5 % sodium azide in
distilled water and the OD read at 450 nm. Results were
expressed as U/ml using a standard curve establish with
human leukocyte myeloperoxidase (Sigma, Poole, U.K.).
Elastase activity in the bronchoalveolar lavage superna-
tant was measured using a fluorogenic substrate highly
specific for neutrophil elastase, Me-Suc-Ala-Ala-Pro-Val-
MCA. Activity present in the bronchoalveolar lavage fluid
was measured fluorimetrically in white maxisorb fluoro-
nunc plates (Life Technologies, UK). 10 µl of cell superna-
tant, total cell lysate or bronchoalveolar lavage fluid was
incubated at 37°C with 90 µl of MCA substrate solution
(0.1 mM in 0.05 M Tris, 0.5 M NaCl, 0.01 M CaCl2, pH
7.5, 10% DMSO). The reaction is continuous and plates
can be read as soon as 10 min after addition of the sub-
strate. For samples with low elastase content, the plates
were read again after 2–4 h, storing the plates in the dark
at room temperature. The cleavage of substrate (increase
in fluorescence of the liberated 4-methyl-7-coumarin)
was measured using a fluorometer set at 370 nm excita-
tion and 460 nm emission. Elastase activity in superna-
tants was calculated based on the results from serial
dilutions of standard human neutrophil elastase (Sigma,
Poole, U.K.).
TNF-α levels were measured on bronchoalveolar lavage
supernatant using a commercially available ELISA kit
(Genzyme Immunobiologicals, Cambridge, UK). The de-
tection limit of this assay was determined to be 15 pg/ml.
The elastase activity and TNF-α levels in the bronchoalve-
olar lavage were measured on fresh samples or samples
stored at -80°C without any loss of activity for up to a
month.
Bronchoalveolar lavage haemorrhage
Bronchoalveolar lavage haemorrhage was measured on
fresh samples. Erythrocytes in the bronchoalveolar lavage
pellet were lysed by adding distilled water for 30 seconds
followed by addition of 2 times concentrated PBS (vol./
vol.). Tubes were then centrifuged at 400 × g for 10 min-
utes and haemoglobin content assessed, in the superna-
tant, by optical density measurement at 414 nm.
Data analysis
Data are expressed as mean ± s.e. means (SEM). Statistical
comparisons were performed using a Kruskall-Wallis test
with Bonferroni correction for multiple comparison and a
P value of less than 0.05 was considered significant.
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